Prof. Dr. Ludwig Plasswilm
Chefarzt/Chefärztin
Radio-Onkologie · Dept. IV
Treatment Options in Oncology
Panje C, Glatzer M, Sirén C, Plasswilm L, Putora P. Treatment Options in Oncology. JCO Clin Cancer Inform 2018; 2:1-10.
01.01.2018Treatment Options in Oncology
01.01.2018JCO Clin Cancer Inform 2018; 2:1-10
Panje Cédric, Glatzer Markus, Sirén Charlotta, Plasswilm Ludwig, Putora Paul Martin
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
von Moos R, Plasswilm L, Zwahlen D, Meier U, Yan P, Izzo P, Klingbiel D, Bärtschi D, Zaugg K, Saletti P, Rauch D, Koeberle D, Schacher S, Hayoz S, Winterhalder R, Roth A, Bodoky G, Samaras P, Berger M, Swiss Group for Clinical Cancer Research (SAKK). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). Eur J Cancer 2017; 89:82-89.
11.12.2017Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
11.12.2017Eur J Cancer 2017; 89:82-89
von Moos Roger, Plasswilm Ludwig, Zwahlen Daniel, Meier Urs R, Yan Pu, Izzo Paola, Klingbiel Dirk, Bärtschi Daniela, Zaugg Kathrin, Saletti Piercarlo, Rauch Daniel, Koeberle Dieter, Schacher Sabina, Hayoz Stefanie, Winterhalder Ralph C, Roth Arnaud, Bodoky György, Samaras Panagiotis, Berger Martin D, Swiss Group for Clinical Cancer Research (SAKK)
Late seed migration after prostate brachytherapy with Iod-125 permanent implants
Maletzki P, Schwab C, Markart P, Engeler D, Schiefer J, Plasswilm L, Schmid H. Late seed migration after prostate brachytherapy with Iod-125 permanent implants. Prostate Int 2017; 6:66-70.
30.09.2017Late seed migration after prostate brachytherapy with Iod-125 permanent implants
30.09.2017Prostate Int 2017; 6:66-70
Maletzki Philipp, Schwab Christoph, Markart Patrick, Engeler Daniel, Schiefer Johann, Plasswilm Ludwig, Schmid Hans-Peter
Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis
Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
16.08.2017Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis
16.08.2017BMC Med Res Methodol 2017; 17:123
Panje Cédric, Glatzer Markus, von Rappard Joscha, Rothermundt Christian, Hundsberger Thomas, Zumstein Valentin, Plasswilm Ludwig, Putora Paul Martin
Temperature dependent dose error of Gafchromic EBT3 and EBT-XD film and clinical relevance in SRT
Buchauer K, Plasswilm L, Schiefer J (2017). Temperature dependent dose error of Gafchromic EBT3 and EBT-XD film and clinical relevance in SRT.
05.05.2017Temperature dependent dose error of Gafchromic EBT3 and EBT-XD film and clinical relevance in SRT
05.05.2017ESTRO 36
Buchauer Konrad, Plasswilm Ludwig, Schiefer Johann
Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
09.03.2017Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
09.03.2017Radiother Oncol 2017; 123:139-146
Warschkow Rene, Gueller Ulrich, Cerny Thomas, Schmied Bruno, Plasswilm Ludwig, Putora Paul Martin
Case report: radio-supersensitive oligometastatic lung cancer
Glatzer M, Putora P, Müller J, Minervini F, Plasswilm L (2016). Case report: radio-supersensitive oligometastatic lung cancer.
25.08.2016Case report: radio-supersensitive oligometastatic lung cancer
25.08.2016SASRO 2016
Glatzer Markus, Putora Paul Martin, Müller Joachim, Minervini F, Plasswilm Ludwig
3D-Druck zur Optimierung der Dosisverteilung eines HDR-Brachytherapie Oberflächenapplikators mit vertikal angeordneter Quelle
Buchauer K, Plasswilm L, Schiefer J (2016). 3D-Druck zur Optimierung der Dosisverteilung eines HDR-Brachytherapie Oberflächenapplikators mit vertikal angeordneter Quelle.
09.06.20163D-Druck zur Optimierung der Dosisverteilung eines HDR-Brachytherapie Oberflächenapplikators mit vertikal angeordneter Quelle
09.06.2016Jahrestagung der Österreichischen Gesellschaft für Medizinische Physik
Buchauer Konrad, Plasswilm Ludwig, Schiefer Johann
Vertical type surface brachytherapy applicator improvement with a 3d printed dose compensation body
Buchauer K, Henke G, Plasswilm L, Schiefer J (2016). Vertical type surface brachytherapy applicator improvement with a 3d printed dose compensation body.
28.04.2016Vertical type surface brachytherapy applicator improvement with a 3d printed dose compensation body
28.04.2016ESTRO 35
Buchauer Konrad, Henke Guido, Plasswilm Ludwig, Schiefer Johann
Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten
Glatzer M, Putora P, Plasswilm L. Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten. SZO 2016
01.03.2016Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten
01.03.2016SZO 2016
Glatzer Markus, Putora Paul Martin, Plasswilm Ludwig
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes
Hundsberger T, Weller M, Plasswilm L, Brügge D, Gross M, Pica A, Hermann E, Pesce G, Conen K, Dietrich P, Migliorini D, Roth P, Roelcke U, Hottinger A, Putora P. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. J Neurooncol 2016; 126:175-183.
01.01.2016Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes
01.01.2016J Neurooncol 2016; 126:175-183
Hundsberger Thomas, Weller M, Plasswilm Ludwig, Brügge Detlef, Gross M W, Pica A, Hermann E, Pesce G, Conen K, Dietrich P Y, Migliorini D, Roth P, Roelcke U, Hottinger A F, Putora Paul Martin
Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
Elicin O, Giger R, Ghadjar P, Geretschlager A, Plasswilm L, Ambarcioglu P, Rauch D, Bromme J, Schmücking M, Aebersold D. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. J BUON 2016; 21:175-81.
01.01.2016Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis
01.01.2016J BUON 2016; 21:175-81
Elicin Olgun, Giger Roland, Ghadjar Pirus, Geretschlager Andreas, Plasswilm Ludwig, Ambarcioglu Pinar, Rauch Daniel, Bromme Jens, Schmücking Michael, Aebersold Daniel M
Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
Putora P, Engeler D, Haile S, Graf N, Buchauer K, Schmid H, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2016; 192:182-9.
01.01.2016Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
01.01.2016Strahlenther Onkol 2016; 192:182-9
Putora Paul Martin, Engeler Daniel, Haile SR, Graf N, Buchauer K, Schmid Hans-Peter, Plasswilm Ludwig
Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
Putora P, Engeler D, Haile S, Graf N, Buchauer K, Schmid H, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2015; 192:182-9.
28.12.2015Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients
28.12.2015Strahlenther Onkol 2015; 192:182-9
Putora Paul Martin, Engeler Daniel, Haile S R, Graf N, Buchauer Konrad, Schmid Hans-Peter, Plasswilm Ludwig
3d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type
Buchauer K, Plasswilm L, Schiefer J (2015). 3d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type.
21.10.20153d printed dose compensation body to remove dose artifacts of a HDR Brachytherapy surface applicator of the vertical type
21.10.2015SSRMP Annual Scientific Meeting 2015 (Fribourg)
Buchauer Konrad, Plasswilm Ludwig, Schiefer Johann
PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
Engeler D, Schmid H, Plasswilm L, Schiefer J, Stucki P, Suter S, Prikler L, Hochreiter W, Thöni A, Schwab C, Putora P. PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-791.
23.06.2015PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator
23.06.2015Strahlenther Onkol 2015; 191:787-791
Engeler Daniel, Schmid Hans-Peter, Plasswilm Ludwig, Schiefer Johann, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thöni Armin F, Schwab Christoph, Putora Paul Martin
Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.
Schiefer J, Buchauer K, Heinze S, Henke G, Plasswilm L. Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison. Strahlenther Onkol 2015; 191:855-61.
19.06.2015Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.
19.06.2015Strahlenther Onkol 2015; 191:855-61
Schiefer Johann, Buchauer Konrad, Heinze Simon, Henke Guido, Plasswilm Ludwig
The SSRMP Tomotherapy Dosimetry Intercomparison 2014
Heinze S, Schiefer J, Buchauer K, Plasswilm L (2015). The SSRMP Tomotherapy Dosimetry Intercomparison 2014.
11.06.2015The SSRMP Tomotherapy Dosimetry Intercomparison 2014
11.06.2015SASRO
Heinze Simon, Schiefer Johann, Buchauer Konrad, Plasswilm Ludwig
Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice
Panje C, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera F, Matzinger O, Plasswilm L, Putora P. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlenther Onkol 2015; 191:778-86.
19.05.2015Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice
19.05.2015Strahlenther Onkol 2015; 191:778-86
Panje Cédric, Dal Pra Alan, Zilli Thomas, R Zwahlen Daniel, Papachristofilou Alexandros, Herrera Fernanda G, Matzinger Oscar, Plasswilm Ludwig, Putora Paul Martin
Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application
Schiefer J, Ingulfsen N, Kluckert J, Peters S, Plasswilm L. Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application. Med Phys 2015; 42:1184-92.
08.03.2015Measurements of isocenter path characteristics of the gantry rotation axis with a smartphone application
08.03.2015Med Phys 2015; 42:1184-92
Schiefer Johann, Ingulfsen Nicholas, Kluckert Jonas, Peters Samuel, Plasswilm Ludwig